Medical Technologies Innovation Asia
1
10M
1
1
- Areas of investment
Summary
The fund was located in Asia if to be more exact in Hong Kong. The main department of described Corporate Investor is located in the Hong Kong.
The standard case for the fund is to invest in rounds with 2 partakers. Despite the Medical Technologies Innovation Asia, startups are often financed by Platinum-Montaur Life Sciences. The meaningful sponsors for the fund in investment in the same round are Platinum Partners.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Echo Therapeutics. Besides, a startup requires to be at the age of more than 20 years to receive the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Therapeutics.
The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2013.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Medical Device (1)
- Biotechnology (1)
- Therapeutics (1)
- Health Care (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 32
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.